Terms: = Germ cell tumor AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
1233 results:
1. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of Social Vulnerabilities of Care and Prognosis in Adult Ocular Melanomas in the US.
Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
4. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
[TBL] [Abstract] [Full Text] [Related]
5. Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.
Michalski K; Schlötelburg W; Hartrampf P; Heinrich M; Serfling S; Buck AK; Werner RA; Kosmala A; Weich A
Mol Imaging Biol; 2024 Apr; 26(2):344-350. PubMed ID: 38332341
[TBL] [Abstract] [Full Text] [Related]
6. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
[TBL] [Abstract] [Full Text] [Related]
7. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract] [Full Text] [Related]
8. Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era.
Hagopian G; Jiang X; Grant C; Brazel D; Kumar P; Yamamoto M; Jakowatz J; Chow W; Tran T; Shen W; Moyers J
ESMO Open; 2024 Feb; 9(2):102193. PubMed ID: 38271786
[TBL] [Abstract] [Full Text] [Related]
9. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
[TBL] [Abstract] [Full Text] [Related]
10. Retinoblastoma treatment in a Brazilian population. Presentation and long-term results.
Bonanomi MTBC; de Almeida MTA; Hollaender MA; Bonanomi RC; Monteiro MLR
Cancer Med; 2024 Feb; 13(3):e6683. PubMed ID: 38243643
[TBL] [Abstract] [Full Text] [Related]
11. Simultaneous melanomas in the setting of multiple primary melanomas.
Kostaki M; Plaka M; Befon A; Dessinioti C; Kypraiou K; Chardalia V; Christofidou E; Polydorou D; Stratigos A
Melanoma Res; 2024 Apr; 34(2):198-201. PubMed ID: 38224405
[TBL] [Abstract] [Full Text] [Related]
12. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
[TBL] [Abstract] [Full Text] [Related]
14. Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma.
Rodrigues MMC; Lederman HM; Grossman I; Castiglioni MLV; Marchetti R; Grass DC; Luisi FAV; Caran EMM
Pediatr Blood Cancer; 2024 Mar; 71(3):e30820. PubMed ID: 38153317
[TBL] [Abstract] [Full Text] [Related]
15. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Beck J; Siebenhüner A; Wild D; Christ E; Refardt J
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38117915
[TBL] [Abstract] [Full Text] [Related]
16. Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
17. Improved staging of Ciliary Body and Choroidal Melanomas Based on Estimation of tumor Volume and Competing Risk Analyses.
Stålhammar G; Coupland SE; Ewens KG; Ganguly A; Heimann H; Shields CL; Damato B
Ophthalmology; 2024 Apr; 131(4):478-491. PubMed ID: 38071620
[TBL] [Abstract] [Full Text] [Related]
18. PATIENT-RELATED FACTORS AND CLINICAL MANAGEMENT OUTCOMES OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
19. Perioperative complication incidence and risk factors for retroperitoneal neuroblastoma in children: analysis of 571 patients.
He M; Cai JB; Wu X; Tang YB; Wang JY; Mao JQ; Chen JJ; Zhang LF; Guan ZH; Xiong JN; Peng WX; Wang JH; Tao T
World J Pediatr; 2024 Mar; 20(3):250-258. PubMed ID: 38070095
[TBL] [Abstract] [Full Text] [Related]
20. Epidemiology, Management, and Survival Outcomes of germ cell Cancer in Southern Portugal: A Population-Based Study (2008-2012).
Brito M; Ramos M; Silva JP; Câmara G; Mayer A; Miranda A; Coelho JLP; Moreira A; Esteves S
Clin Genitourin Cancer; 2024 Feb; 22(1):e170-e177.e1. PubMed ID: 38061978
[TBL] [Abstract] [Full Text] [Related]
[Next]
